|
|
|
|||||
Archive:
| |||||
ScienceDaily (May 2, 2008) A new surgical procedure for head and neck cancer at the University of Alabama at Birmingham offers improved accuracy for surgeons and reduced post-operative pain for patients ... The new procedure uses robotic surgery, and results have shown it lessens the scarring, breathing problems and damage to speech that can happen with treating head and neck cancers, said William Carroll, M.D., a scientist in the UAB Comprehensive Cancer Center ... "This application takes... (Science Daily)
Possible Viral Links to Lung Cancer Risk Uncovered May 2, 2008
It has also recently been implicated as a possible cause for head and neck cancer. Further studies are planned to look for signs of HPV infection in the respiratory tract of lung cancer patients and to explore the possibility for using HPV infection as a screening indicator for the disease. (MEDLINEplus)
Health/Science calendar Apr 21, 2008
FRI., APRIL 25Free cancer screening Massachusetts Eye and Ear Infirmary will provide free head and neck cancer screening. From 9 a.m. to 3 p.m., Massachusetts Eye and Ear Infirmary, 11th floor, 243 Charles St. For reservations call 617-573-4084. (Boston Globe)
HEALTH BRIEFS Apr 16, 2008
head, neck cancers The Oregon Health & Science University Cancer Institute will host a free head and neck cancer screening and awareness day ... Head and neck cancers affect the scalp, face, nose, mouth, throat, thyroid and neck. (OregonLive, OR -- News)
It's Neck-and-neck Down The Long Stretch For 2 Stroke-prevention Procedures Apr 15, 2008
22, 2007) Giving patients with head and neck cancer a combination of chemotherapy and radiation therapy controls the cancer and allows many patients to avoid additional surgery to the neck, according to a ... (May 16, 2007) Cigarette smoking is more strongly associated with head and neck cancers than drinking alcohol, according to a new study. (Science Daily)
DNA Paternity Test Almost Fooled: Man Put Someone Else's Saliva In His Mouth Apr 13, 2008
5, 2008) A morning gargle could someday be more than a breath freshener -- it could spot head and neck cancer, say scientists. Their new study of a mouth rinse that captures genetic signatures common to the. (Science Daily)
YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING Apr 12, 2008
" About YM BioSciences YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company has two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is approved in several countries for treatment of various types of head and neck cancer; and AeroLEF(TM), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl... (PR Newswire)
Cancer Stem Cells Created With New Technique Apr 12, 2008
Clarke has since moved to Stanford, where he is the Karel H. and Avice N. Beekhuis Professor in Cancer Biology, and Stanford has become a leader in cancer stem cell research, with teams finding cancer stem cells in head and neck cancer, colorectal cancer and additional blood cancers. Laboratory researchers at the medical school are also beginning to work with clinical groups to apply cancer stem cell findings to patient care. (Science Daily)
Former racer headed back to Daytona Apr 12, 2008
Bobby Hamilton Racing is urging fans to take part in the Oral, Head and Neck Cancer Awareness Week from April 21 to 27. More than 150 medical centers across the nation will hold free screenings. (Yahoo News -- Auto Racing)
Ear, Nose, And Throat Specialist Joins FCMC Apr 11, 2008
He completed his residency at P.C.O.M., with specialty training at Buffalo General Hospital, New York, in head and neck cancer surgery and Shadyside Hospital, Pittsburgh, Pa. in advanced sinus surgery and facial nerve surgery. (Fulton County News, PA)
Mayo Clinic identifies treatment target for liver cancer recurrence and survival Apr 11, 2008
In 2007, Dr. Lai presented information at the annual meeting of the American Association for Cancer Research on the role of SULF2 in survival of patients with head and neck cancer -- the first concrete link to survival of patients with a specific tumor type. . (EurekAlert!)
Double binding sites on tumor target may provide future combination therapy Apr 9, 2008
Three years ago, Kate Ferguson, PhD, Assistant Professor of Physiology, and colleagues determined the precise molecular details of how Erbitux, a colorectal and head and neck cancer drug, binds to its target on cancer cells. EGFR drugs halt cell proliferation by blocking EGFRs molecular doorway, keeping hormones from binding and signaling tumor growth. (EurekAlert!)
HPV, Periodontitis Work In Tandem To Increase Risk Of Tongue Cancer Apr 7, 2008
Studies conducted elsewhere have found that HPV is an independent risk factor for a subset of head and neck cancers ... If these results are confirmed by other studies, this has a tremendous relevance in predicting and intervening in the initiation and prognosis of HPV-related diseases, including head and neck cancers ... " The study involved 30 patients newly diagnosed with squamous cell carcinoma on the base of the tongue between 1999 and 2005 at Roswell Park Cancer Institute for whom data was... (Science Daily)
'Liquor + fag = Cancer' Apr 7, 2008
Delivering a keynote address on the concluding day of the International Conference on Head and Neck Cancer organised under the aegis of Mahavir Cancer Sansthan (MCS) here, Dr Hosal said the government must come forward to check the growing menace of cancer in India ... The new building would be constructed on the MCS campus at a cost of Rs 8 crore to provide better medical facilities to head and neck cancer patients, he said adding about 42 per cent of the cancer patients in Bihar were suffering... (India Times, India -- Health/Science)
Inhibition of Chemokine Receptor Activation May Improve Head and Neck Cancer Therapies, Study Suggests Mar 27, 2008
5 percent reduction in viability after treatment with a targeted therapy, called erlotinib, that is already being used in squamous cell head and neck cancer treatment ... (May 16, 2007) Cigarette smoking is more strongly associated with head and neck cancers than drinking alcohol, according to a new study. (Science Daily)
Ontario ordered to pay woman's U.S. medical bills Mar 27, 2008
The cancer treatment offered "fell short of appropriate care for someone in her circumstances," according to the letter from Dr. Ensley, who specializes in head and neck cancer at Barbara Ann Karmanos Cancer Center. The treatment plan in Windsor might not have used the same chemotherapy drugs in the same high doses, in the same manner. (Globe and Mail)
Identical Genes from Parents May Raise Cancer Risk Mar 27, 2008
So, Eng and her colleagues decided to look at 400 genetic markers scattered throughout the genome in 385 breast, prostate and head and neck cancer patients and in people without cancer. All patients were of the same ethnic group. (MEDLINEplus)
Head and Neck Cancer Outcomes a Mixed Bag Mar 20, 2008
In background information in the study, the researchers noted that head and neck cancer treatment such as feeding tube placement, chemotherapy and radiation "tend to produce pain, disfigurement, eating problems and communication problems. Many patients become disabled, and about one-third of patients continue to smoke, and half are depressed.". This study by David L. Ronis, of the Veterans Affairs Ann Arbor Healthcare System and the University of Michigan School of Nursing, Ann Arbor, and... (MEDLINEplus)
Cause Of Severe Allergic Reaction To Cancer Drug Found Mar 17, 2008
16, 2008) Clinicians have been perplexed by the fact that some patients given the drug cetuximab--an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer--have a severe and rapid adverse reaction to the drug ... 19, 2007) Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to. (Science Daily)
Factors behind Head and Neck Cancer Revealed Mar 15, 2008 Amgen, J&J Anemia Treatments May Face U.S. Restrictions as Cancer Medicine Mar 7, 2008 Chemotherapy in Unresectable Head and Neck Cancer Mar 6, 2008 EU Commission Approves Updated Prescribing Information for Aranesp(R) Mar 5, 2008 PET/CT planning beneficial for head and neck cancer patients Mar 5, 2008 Drug For Anemic Cancer Patients Raises Risk Of Death, Study Shows Feb 29, 2008 Study Finds Variations in Doses of Radiation Therapy Feb 28, 2008 Study finds increased risk of death from anemia drugs Feb 27, 2008 Genmab Agrees to Buy Minnesota Biotech Manufacturing Plant from ... Feb 22, 2008 HPV-Positive Head and Neck Cancers Fare Better Feb 14, 2008 Vitamin A And Zinc Supplement May Help Protect Children From Malaria, Study Suggests Feb 8, 2008 Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data Jan 29, 2008 Exelixis CEO says planning pivotal trials and partnerships this year Jan 18, 2008 Four Health Behaviors Can Add 14 Extra Years Of Life Jan 10, 2008 GeneNews appoints three leading cancer screening experts to its Clinical Advisory Board Jan 7, 2008 Gargling Could Help Detect Cancer Jan 3, 2008 Morning gargle may be used for cancer tests Jan 3, 2008 A 'swish-and-spit' test for cancer Jan 2, 2008 Victor Navarra, 55; firefighter was key NYC Marathon official Jan 1, 2008 NYC Marathon coordinator, 9/11 firefighter dies Jan 1, 2008 "Swish-and-spit" test screens for cancer Jan 1, 2008 Mouthwash 'could detect cancer' Jan 1, 2008 Gold nanoparticle probes may allow earlier cancer detection Dec 25, 2007 Exelixis fills pipeline, but still no drug Dec 24, 2007 Race, Gender Affect Laryngeal Cancer Survival Dec 21, 2007 Glaxo opts to pick up Exelixis cancer compound Dec 15, 2007 Kids Eat More Fruits, Vegetables When Schools Offer Salad Bar Dec 8, 2007 Reducing Pain via Hypnosis, This Week on Your Cancer Today (TM) Dec 7, 2007 Drinking And Smoking Don't Boost HPV-related Cancer Risk Nov 29, 2007 University Cancer Center's patient nutrition initiative sees success Nov 28, 2007 Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA Nov 27, 2007 More on Cetuximab in Head and Neck Cancer Nov 22, 2007 Mangalore: Central Research Lab Inaugurated at Derlakatte Nov 15, 2007 NHS in England to deny arthritis treatment Nov 13, 2007 YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS Nov 12, 2007 Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers Oct 31, 2007 PET/CT Combination Can Highly Increase Detection Of Colorectal Cancer Oct 30, 2007 Integrated approach to IMRT provides quality care for head and neck cancer patients Oct 29, 2007 Bad news for Pollyannas who peddle false hopes Oct 27, 2007 Taxotere Improves Survival in Head-Neck Cancer Oct 27, 2007 Improving Head and Neck Cancer Survival Oct 25, 2007 TPF Therapy in Unresectable Head and Neck Cancer Oct 25, 2007 Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer Oct 25, 2007 Upbeat attitudes don't beat cancer Oct 24, 2007 Emotional State Doesn't Affect Cancer Survival Oct 24, 2007 Merck KGaA Profit Slumps 75 Percent on Writedowns From Serono Acquisition Oct 24, 2007 When it comes to cancer 'mind over matter'...doesn't matter Oct 24, 2007 Emotions do not affect cancer survival Oct 23, 2007 Emotional well-being doesn't affect cancer outcome Oct 23, 2007 Positive thought has no power over cancer Oct 23, 2007 Optimism 'no bearing on cancer' Oct 22, 2007 1st Kuwaiti woman MP sworn in Oct 22, 2007 Cancer survival is not influenced by a patient's emotional status Oct 22, 2007 Fruit compound fights some cancers Oct 17, 2007 HK experts reveals lupeol in fruits helps combat cancer Oct 17, 2007 Study finds fruit key in cancer fight Oct 17, 2007 Advaxis, Inc. phase I/II results of lovaxin C in cervical cancer study released Oct 11, 2007 FDA approves Sanofi's Taxotere for head and neck cancer Oct 3, 2007 Cancer drug Taxotere given the green light to treat head and neck ... Oct 3, 2007 Taxotere Gets FDA Approval For Advance Head And Neck Cancer Before ... Oct 2, 2007 Sanofi's Taxotere gets US approval for use in head and neck cancer Oct 2, 2007 Alcohol And Cancer: Is Drinking The New Smoking? Sep 28, 2007 Patients With Head And Neck Cancer May Have Impairment Of Some Driving Skills Sep 19, 2007 Cancer Care Might Impair Driving Sep 19, 2007 Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer Sep 13, 2007
WASHINGTON (Reuters) - There are two distinct culprits behind head and neck cancer -- the long-recognized heavy tobacco and alcohol use as well as a common sexually transmitted virus, researchers said on Tuesday. The risk factors are so dramatically different in head and neck cancer in people infected with the human papillomavirus, or HPV, that it should be considered a separate disease from cases in which patients are not infected, researchers at Johns Hopkins University in Baltimore said ...... (MEDLINEplus)
All The Wrong Numbers Mar 15, 2008
Thursday, Amgen shares surged 5% as advisers told the Food and Drug Administration to warn patients not to use the company's top-selling anemia drug for head and neck cancer, breast cancer or in any case where patients might be cured of their cancer by chemotherapy. Investors had expected worse. (Forbes -- Business)
The FDA urged doctors a year ago to use the lowest doses possible after dangers were seen in patients with kidney disease and head and neck cancer. An advisory panel is scheduled to discuss the new studies next week. (Bloomberg -- US)
To the Editor: Radiotherapy alone in patients with advanced head and neck cancer is not the treatment of choice, even when cisplatin, fluorouracil, and docetaxel (TPF) are given ... 25 issue)1 report that TPF improved progression-free and overall survival in patients with unresectable head and neck cancer, but their results are disappointing as compared with chemoradiotherapy2,3 or radiotherapy with cetuximab ... 4 In the same issue, Posner et al. also report better results in patients with... (New England Journal of Medicine)
ESA trials have shown an unexplained excess mortality in association with high target hemoglobin concentrations (greater than 12 g/dL), including (1) shortened time to tumor progression in patients with advanced head and neck cancer receiving radiation therapy; (2) shortened overall survival in patients with metastatic breast cancer receiving chemotherapy; (3) increased risk of death when administered to target a hemoglobin of 12g/dL (7. 5 mmol/l) in patients with active malignant disease... (BusinessWire)
That study was the largest randomized trial of radiation therapy in locally advanced head and neck cancer. Disease free survival for the 42 study patients was 71 percent and 66. (EurekAlert!)
Lai, a head and neck surgeon, saw a significant effect when he added an ESA called erythropoietin to head and neck cancer cells in tissue culture. "We saw a dramatic change," Lai said. (Science Daily)
Twelve percent of the participants had brain cancer, 26 percent had head and neck cancer, while 62 percent had prostate cancer. The patients were treated at five different medical centers, each using different planning systems for the therapy. (MEDLINEplus)
One option that analysts expect to be discussed at the meeting in March would be to bar the use of the drugs for specific types of cancer, like breast cancer and head and neck cancer. Another would be to delay treatment with the drugs until patients became more anemic than the current threshold, a change that would more closely match the Medicare reimbursement policy. (International Herald Tribune)
Diseases targeted by its products include leukemias, lymphomas, rheumatoid arthritis, and head and neck cancer. Genmab's antibodies also have potential for treatment of many other diseases. (FOXBusiness)
TUESDAY, Feb. 12 (HealthDay News) -- Head and neck cancer patients whose tumors test positive for human papillomavirus (HPV) tend to survive longer and respond better to treatment than those who test negative, a new study says. HPV, a common virus with strains believed to be responsible for most cervical cancers, has recently been linked to the development of some head and neck cancers, particularly those of the upper throat, or oropharynx. (MEDLINEplus)
3, 2007) Zinc sulfate, a supplement thought to be helpful in regaining the sense of taste for some head and neck cancer patients after radiation therapy, has been found to have no significant impact on. (Oct. (Science Daily)
Proxinium(TM) is undergoing a global pivotal Phase 3 trial (the 'TARGET' trial) in approximately 300 patients with advanced head and neck cancer ... Proxinium(TM) Viventia's lead drug, Proxinium(TM), is a humanized antibody fragment conjugated to the cytotoxic protein Pseudomonas exotoxin A. The drug is in a global pivotal Phase 3 clinical trial (the 'TARGET' trial) in patients with advanced head and neck cancer ... Viventia's lead product, Proxinium(TM), is undergoing a global Phase 3 clinical... (Canada Newswire)
XL880 is a small-molecule MET inhibitor in Phase II for papillary renal cell carcinoma, gastric cancer and head and neck cancer. Scangos said more renal and gastric cancer data are expected at ASCO.. (FT.com -- Markets)
9, 2008) People who adopt four healthy behaviours -- not smoking; taking exercise; moderate alcohol intake; and eating five servings of fruit and vegetables a day -- live on average an additional fourteen years of life compared with people who adopt none of these behaviours, according to a new study. Rather than focusing on how an individual factor is related to health, the study calculates the combined impact of these four simply-defined forms of behaviour. (Science Daily)
David Sidransky, MD Dr. Sidransky is currently the Director of the Head and Neck Cancer Research Program at the Sidney Kimmel Comprehensive Cancer Center and is Professor of Oncology, Urology, Cellular ular Medicine, Pathology, Otolaryngology and Genetics at Johns Hopkins University School of Medicine. He received his undergraduate degree from Brandeis University and his medical degree from Baylor College of Medicine. (Canada Newswire)
" But he said a panel of markers chosen from a more extensive initial set of genes is already showing better results in research now being conducted by his group. The method is simple -- a patient brushes the surfaces of the oral cavity with an exfoliating brush, then gargles and rinses with 20 milliliters of normal saline. A specialized form of polymerase chain reaction allows the detection of hypermethylated tumor suppressor genes in the salivary rinse. Hypermethylation prevents transcription... (MedPage Today)
BEIJING, Jan. 3 (Xinhuanet) -- Morning gargle could be used some day as one way for people to find whether they have head and neck cancer, U.S. researchers said as quoted by media reports Thursday. Scientists at the Johns Hopkins Kimmel Cancer Center in Baltimore tried to use mouth rinses that capture genetic signatures linked to cancer as a screening tools for heavy smokers and alcohol drinkers -- those at high risk for head and neck cancers ... The scientists filtered out cells in the rinsed... (Xinhuanet, China)
WASHINGTON: A simple mouth rinse may provide a new way to screen for head and neck cancers in people at high risk for these diseases, researchers said on Tuesday ... The scientists filtered out cells in the rinsed saliva that might contain one or more of 21 bits of chemically altered genes associated with head and neck cancers ... Experts say the vast majority of head and neck cancer cases are linked to tobacco use, including smoking and smokeless tobacco. (India Times, India -- Health/Science)
He died Sunday of head and neck cancer that he believed was caused by his work at the site, his family said. Mr. Navarra, an avid runner, first volunteered for the marathon in 1981 and became start coordinator in 1983, family spokeswoman and friend Terry Raskyn said. (Boston Globe)
He died Sunday of head and neck cancer that he believed was caused by his work at the site, his family said. Navarra, an avid runner, first volunteered for the marathon in 1981 and became start coordinator in 1983, family spokeswoman and friend Terry Raskyn said. (Newsday -- New York City)
WASHINGTON (Reuters) - A simple mouth rinse may provide a new way to screen for head and neck cancers in people at high risk for these diseases, researchers said on Tuesday ... The scientists filtered out cells in the rinsed saliva that might contain one or more of 21 bits of chemically altered genes associated with head and neck cancers ... Experts say the vast majority of head and neck cancer cases are linked to tobacco use, including smoking and smokeless tobacco. (Yahoo News -- Top Stories)
A mouth wash could help to detect head and neck cancer, scientists say ... A mouthwash that identifies genetic material has the potential to screen for head and neck cancer in at-risk people, scientists claim ... They asked 211 head and neck cancer patients and 527 people without cancers of the mouth, larynx or pharynx to brush their inside of their mouths and then rinse and gargle with a salt solution. (InTheNews.co.uk)
"It is also a product of inter-programmatic collaboration between two NIH-funded centers at Emory and Georgia Tech, one for cancer nanotechnology and one for studying head and neck cancer.". . (EurekAlert!)
The drug, now in Phase II trials, also may treat gastric cancer and head and neck cancer. It is one of 12 compounds that Exelixis is moving through the clinic, a rich number compared with many biotechs. (San Francisco Business Times, CA)
The study was published in the December issue of the Archives of Otolaryngology -- Head and Neck Cancer. More information. (Forbes)
GlaxoSmithKline (NYSE: GSK) said it exercised an option to exclusively license XL880, a compound in Phase II trials to treat patients with papillary renal cell carcinoma -- a type of kidney cancer -- gastric cancer and head and neck cancer. A $35 million milestone payment to South San Francisco-based Exelixis will be applied to an advance that GSK paid Exelixis in 2005. (San Francisco Business Journal)
16, 2007) A new study among AARP members shows that just one additional serving of fruit and vegetables per day may lower your risk of head and neck cancer, but the data suggest that you may not want to stop. . (Science Daily)
How prevalent is head and neck cancer ... Dr Stan Wasbin, Medical Director for Your Cancer Today, provides an overview of head and neck cancer, including the fact that men are 3 times as likely to contract head and neck cancer as women ... A new treatment protocol for head and neck cancer is proving more effective than traditional treatment. (Yahoo! Wire -- Entertainment News)
28, 2007) Heavy smoking and drinking are known to cause head and neck cancer. Infection with human papilloma virus type 16 (HPV16), a common strain of the sexually-transmitted HPV virus, is another known risk factor for head and neck cancer, which affects about 500,000 people each year worldwide ... New Brown University research, however, shows that alcohol and tobacco use doesn t further increase the risk of contracting head and neck cancers for people infected with HPV16. (Science Daily)
While the program recently expanded to be available to all cancer patients, Read said a majority of patients who benefit suffer from some type of head and neck cancer. These cancer patients tend to have the most problems with weight loss because treatment can often result in difficulty swallowing. (The Cavalier Daily, VA)
ADVEXIN is also being developed for head and neck cancer and filings for this indication are anticipated before the end of 2007 both in Europe and the US. ... ADVEXIN has demonstrated tumor growth control in recurrent head and neck cancer, lung cancer, breast cancer, esophageal, prostate and other cancer indications. (BusinessWire)
9, 2006, issue)1 reports a survival advantage with the addition of concurrent cetuximab to radiotherapy in patients with advanced head and neck cancer. In addition, cetuximab improved locoregional control but had no effect on distant metastases. (New England Journal of Medicine)
The ongoing research initiatives include head and neck cancer, dental caries, periodontal, dental material research, HIV- AIDS research etc. Dr B.Rajendra Prasad, principal and dean, Dr N Sridhar Shetty, director, Speciality Training Centre, Dr U S Krishna Nayak, dean, Academics, Dr Gopakumar R, research coordinator were also present on the occasion. (Daijiworld.com)
Erbitux Used to treat head and neck cancer. Costs 11,000 per patient and can prolong life by around 20 months when it is combined with radiation therapy. (Telegraph.co.uk)
The Company has two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is approved in several countries for treatment of various types of head and neck cancer; and AeroLEF(TM), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe pain, including cancer pain. This press release may contain forward-looking statements, which reflect the... (PR Newswire)
WEDNESDAY, Oct. 24 (HealthDay News) -- The addition of the chemotherapy drug, docetaxel, to the standard two-drug regimen used for head and neck cancers improved the efficacy of the treatment while reducing the toxicity, two new studies report ... "This is a study that demonstrates that a three-drug regimen is better by a substantial amount in terms of survival for head and neck cancer. There was a 30 percent reduction in mortality with less toxicity," said Dr. Marshall R. Posner, lead author of... (MEDLINEplus)
1, 2005) A highly powerful scanner combining two state-of-the-art technologies -- computed tomography (CT) and positron emission tomography (PET) -- may detect the spread of head and neck cancer more. (Dec. (Science Daily)
LOS ANGELES, Oct. 28 Results from a University of Pittsburgh study demonstrate that intensity-modulated radiation therapy (IMRT) for head and neck cancer can be uniformly delivered in a large health care system of academic and community cancer centers through a centralized planning and treatment process ... Our study demonstrates that it is feasible for head and neck cancer patients to receive IMRT in their own communities without sacrificing high-quality care, said Dwight Heron, M.D.,... (EurekAlert!)
Among the 1093 patients with head and neck cancer who were studied by researchers from the University of Pennsylvania School of Medicine, those who had an optimistic outlook did no better or worse than the more gloomy ones. The study followed the patients for 10 years, and left no stone unturned. (Sydney Morning Herald -- Opinion)
BOSTON (Reuters) - Adding the Sanofi-Aventis cancer drug Taxotere to standard chemotherapy helps people with head and neck cancer live more than three years longer, two teams of researchers reported on Wednesday ... "Here you see the first improvement in head and neck cancer treatment in almost 25 years and it's basically the addition of this drug Taxotere," said Marshall Posner of the Dana-Farber Cancer Institute in Boston, leader of one of the studies ... About 11,000 people in the United... (MEDLINEplus)
(Ivanhoe Newswire) -- Head and neck cancers affect more than 40,000 people in the United States every year and more than 500,000 worldwide ... Now, two treatment therapies are making a big difference in the survival of patients suffering from advanced head and neck cancers ... Standard initial treatment for advanced head and neck cancers is chemotherapy. (Ivanhoe)
NEJM -- Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer ... Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer. (New England Journal of Medicine)
Please for full text and personal services. Volume 357:1705-1715. (New England Journal of Medicine)
Dr. James Coyne and colleagues from the University of Pennsylvania included 1,093 patients in the study with head and neck cancer who completed quality-of-life questionnaires during their treatment. This is one of the largest and most rigorously designed investigations ever to examine the issue. (Xinhuanet, China)
University of Pennsylvania researchers say that among head and neck cancer patients, emotional health -- good or bad -- is not an independent factor affecting prognosis ... The study, expected to be published in the Dec. 1 issue of Cancer, culled data from almost 1,100 patients enrolled in two phase III clinical trials for new head and neck cancer treatments ... "In a separate study, we found that single males with head and neck cancer appeared to be at risk for lower survival... and in another... (MEDLINEplus)
Merck sees better growth prospects on the cancer market with its Erbitux treatment for bowel cancer and head and neck cancer, which it licensed from ImClone Systems Inc. in 1998. Third- quarter sales from the medicine rose 36 percent to 118 million euros, and Merck is seeking to expand its use to other tumor types. (Bloomberg -- Europe)
A study by researchers at the University of Pennsylvania team tracked 1,093 patients suffering from head and neck cancer; of these 646 died during the period of the study. The patients, from two Radiation Oncology Group clinical trials completed a quality of life questionnaire known as the Functional Assessment of Cancer Therapy-General (FACT-G) at the start of the trials. (News-Medical.net)
They analyzed data from two studies of the emotional states of 1,093 patients with head and neck cancer. advertisement. (MSNBC -- Health)
Of 1,093 head and neck cancer patients who provided information on their emotional health during their cancer treatment, Dr. James C. Coyne of the University of Pennsylvania, Philadelphia and colleagues found that emotional well-being was not a predictor of survival. Altogether, 646 patients died during the 1992-2000 study and emotional status was not related to survival, even after adjusting for several other factors like gender, characteristics or stage of the tumor, the team reports in the... (Reuters)
Instead, he used data from two studies of patients with head and neck cancer to examine whether emotional wellbeing at the time the study started had any effect on survival. His sample consisted of 1093 patients who completed a quality-of-life questionnaire during treatment. (NEWS.com.au)
The University of Pennsylvania team followed more than 1,000 patients with head and neck cancer. But experts said the Cancer journal study should not deter people from adopting a "fighting spirit". (BBC News -- Health)
Researchers at the University of Pennysylvania found that the emotional states of patients suffering from head and neck cancer had no impact on their survival. U.S. researchers have found that the more sun exposure that light-skinned women receive, the lower their risk of advanced breast cancer. (Yahoo News -- Kuwait)
Published in the December 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study found that emotional well-being was not an independent factor affecting the prognosis of head and neck cancers ... Dr. Coynes team analyzed data from two community studies of patients with head and neck cancer to examine whether emotional well being at study entry predicted survival ... The sample included 1,093 patients with head and neck cancer who completed a quality of life... (EurekAlert!)
Head and neck cancers involve cancers of the nose, oral cavity, throat, voice box, thyroid and salivary glands and they more commonly afflict Asians than Westerners ... In the experiment, lupeol was given to mice infected with malignant head and neck cancer cells. (MSNBC -- Health)
HONG KONG, Oct. 16 (Xinhua) -- A study found that a substance called "lupeol" contained in fruits may help beat head and neck cancer, announced the University of Hong Kong which made the result public here Tuesday ... Head and neck cancer includes cancers of the nose, oral cavity, salivary gland, etc ... Human papilloma virus infection, alcohol and tobacco consumption and low fruits and vegetables intake all contribute to the increased risk of head and neck cancer development. (Xinhuanet, China)
A compound found in mangoes, grapes, strawberries and other fruit holds the key to fighting head and neck cancer ... The researchers said only a slight change in diets can have an astounding impact in the treatment of head and neck cancer, such as those of the nose, oral cavity, pharynx, larynx and thyroid and salivary gland ... According to the researchers, head and neck cancer is the third most common form of cancer. (The Standard)
Lovaxin C is being developed by Advaxis as an immunotherapy that is intended to treat patients with cancers that result from human papilloma virus (HPV), including cervical cancer and head and neck cancer ... Advaxis' lead Listeria vaccine candidate, Lovaxin C, targets cervical and head and neck cancers. (EurekAlert!)
FDA approves Sanofi's Taxotere for head and neck cancer - The Money Times ... FDA approves Sanofi's Taxotere for head and neck cancer ... The drug can now be used for the treatment of locally advanced head and neck cancer prior to chemo-radiotherapy and surgery. (The Money Times)
Cancer drug Taxotere given the green light to treat head and neck cancer ... Cancer drug Taxotere given the green light to treat head and neck cancer ... Cancer drug Taxotere given the green light to treat head and neck cancer. (News-Medical.net)
Taxotere Gets FDA Approval For Advance Head And Neck Cancer Before Chemoradiotherapy And Surgery ... Taxotere Gets FDA Approval For Advance Head And Neck Cancer Before Chemoradiotherapy And Surgery ... Clinical investigator, Marshall Posner, MD, Medical Director of the Head and Neck Oncology Program at Dana-Farber Cancer Institute in Boston, said "The TAX 324 trial found that the addition of Taxotere to standard induction chemotherapy significantly improved patient survival, adding years to... (Medical News Today)
Sanofi's Taxotere gets U.S. approval for use in head and neck cancer - MarketWatch. latest news Sanofi's Taxotere gets U.S. approval for use in head and neck cancer Last Update: 5:44 AM ET Oct 1, 2007 ... The drug has been approved to treat locally advanced head and neck cancer prior to chemoradiotherapy and surgery, Sanofi-Aventis said. (MarketWatch)
Researchers at the Centre for Addiction and Mental Health (CAMH) have clarified the link between alcohol consumption and the risk of head and neck cancers, showing that people who stop drinking can significantly reduce their cancer risk ... Risk of head and neck cancer only reduced significantly after 10 years of cessation ... Said Dr. Rehm, "Alcohol cessation has very similar effects on risk for head and neck cancers as smoking cessation has on lung cancer. It takes about two decades before the... (Science Daily)
D., O.T.R./L., of the Medical University of South Carolina, Charleston, and colleagues used a virtual reality driving simulator to evaluate the driving skills of 10 patients with head and neck cancer (average age 56) and 50 members of the community (average age 48). Researchers recorded average speed, average brake reaction time, steering variability (vehicle offset from the center of driving lane in inches), the total number of collisions and the score of the Simulator Driving Performance... (Science Daily)
MONDAY, Sept. 17 (HealthDay News) -- Side effects of treatment for head and neck cancer may cause patients to experience problems with driving skills, a new study suggests ... They evaluated the driving skills of 10 head and neck cancer patients (average age 56) and a control group of 56 people in the general community (average age 48). (MEDLINEplus)
The Mount Sinai Medical Centers Head and Neck Cancer Center is teaming up with ENT and Allergy Associates, LLP to help fight cancer ... Mount Sinais new collaboration with ENT and Allergy Associates marks an exciting venture in cancer care outside the city limits, said Dr. Eric Genden, Professor and Chairman of the Department of Otolaryngology and Director of the Head and Neck Cancer Center at Mount Sinai ... Mount Sinai and ENT partnership will establish a series of thyroid and head and neck... (EurekAlert! -- Business News)
Back to FindHealthNews Home
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.
Copyright SurfWax, Inc. 2006 |